Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatohepatitis Caused by Ingestible Alcohol”

341 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 341 results

Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Not applicableStudy completedNCT01464801
What this trial is testing

Resveratrol in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
University of Aarhus 28
Not applicableStudy completedNCT01695083
What this trial is testing

Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients

Who this might be right for
Morbid ObesityNon Alcoholic Steatohepatitis
Assistance Publique - Hôpitaux de Paris 186
Post-approval studies (Phase 4)Not Yet RecruitingNCT07180745
What this trial is testing

Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease NAFLDNon-alcoholic Steatohepatitis NASH
Badr University 400
Not applicableActive Not RecruitingNCT02754037
What this trial is testing

Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)
University of California, Davis 120
Early research (Phase 1)Study completedNCT03513588
What this trial is testing

2-Week Study In People With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic SteatohepatitisNon-alcoholic Fatty Liver Disease
Pfizer 48
Post-approval studies (Phase 4)Study completedNCT04537780
What this trial is testing

Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non Alcoholic Steatohepatitis
Tanta University 44
Not applicableUnknownNCT05217745
What this trial is testing

MLCT Oil for Fatty Liver - PASS Trial

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisNAFLD
National University Hospital, Singapore 30
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Testing effectiveness (Phase 2)Study completedNCT04342793
What this trial is testing

Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis
AngioLab, Inc. 60
Not applicableStudy completedNCT05426382
What this trial is testing

A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sidekick Health 38
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Testing effectiveness (Phase 2)Study completedNCT02923154
What this trial is testing

Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)

Who this might be right for
NASH
Tanabe Pharma Corporation 48
Early research (Phase 1)Study completedNCT02612662
What this trial is testing

Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT03008070
What this trial is testing

Phase 2b Study in NASH to Assess IVA337

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Inventiva Pharma 247
Post-approval studies (Phase 4)Study completedNCT00994682
What this trial is testing

University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 176
Testing effectiveness (Phase 2)Study completedNCT06054815
What this trial is testing

Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

Who this might be right for
NON-ALCOHOLIC STEATOHEPATITIS
NeuroBo Pharmaceuticals Inc. 109
Testing effectiveness (Phase 2)Study completedNCT04328077
What this trial is testing

LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc. 101
Testing effectiveness (Phase 2)Study completedNCT04932512
What this trial is testing

Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

Who this might be right for
Steatohepatitis, Nonalcoholic
Ionis Pharmaceuticals, Inc. 160
Load More Results